Publications by authors named "Tardu OEzkartal"
The Clinical Significance of Atrial Fibrillation in Non-High-Risk Brugada Syndrome: The BruFib Study.
JACC Clin Electrophysiol
August 2025
Background: Atrial fibrillation (AF) occurs in up to 20% of patients with Brugada syndrome (BrS), yet its risk factors and prognostic implications remain uncertain.
Objectives: This study sought to identify risk factors for AF in patients with non-high-risk BrS and to evaluate the impact of AF on ventricular arrhythmias (VAs), sick sinus syndrome (SSS), and stroke in non-high-risk BrS.
Methods: This was a multicenter, retrospective study conducted across 20 international centers.
Article Synopsis
- * AAs were the first symptom of IAS in 52% of patients, and nearly a quarter had multiple AAs documented.
- * The study found a moderate incidence of severe outcomes, including a yearly primary endpoint rate of 1.4%, with younger patients experiencing higher risks and other complications affecting some patients as well.
Article Synopsis
- Leadless pacemaker (LP) implantation is becoming a viable alternative for patients with prior conventional pacing systems (CPS), with a study analyzing its safety and effectiveness in 257 patients from two Swiss centers.
- Out of the patients studied, 24 had previous CPS, and a significant number (83%) required lead extraction due to various issues, while LP implantation showed low complication rates overall.
- Results indicated that LP implantation was effective and safe even in patients with prior CPS, as no infections or complications occurred after the procedures, contributing to positive outcomes in this population.
Background: Impairment of the conduction system is a common complication of transcatheter aortic valve replacement (TAVR), which is typically performed in elderly patients. A leadless pacemaker (LP) may be a suitable option in this frail population, but the available scientific data concerning the efficacy and safety of leadless pacing after TAVR are sparse. The purpose of this analysis was to evaluate the efficacy and safety of LP implantation in patients with relevant bradycardias after TAVR, compared to other indications.
View Article and Find Full Text PDFBackground And Aims: The Utstein Based-ROSC (UB-ROSC) score has been developed to predict ROSC in OHCA victims. Aim of the study was to validate the UB-ROSC score using two Utstein-based OHCA registries: the SWiss REgistry of Cardiac Arrest (SWISSRECA) and the Lombardia Cardiac Arrest Registry (Lombardia CARe), northern Italy.
Methods: Consecutive patients with OHCA of any etiology occurring between January 1st, 2019 and December 31st 2021 were included in this retrospective validation study.
Background: Almost 1/3 of heart failure patients fail to respond to cardiac resynchronization therapy (CRT). A simple clinical score to predict who these patients are at the moment of referral or at time of implant may be of importance for early optimization of their management.
Methods: Observational study.